ask="24.50"
ask_size="100"
average_daily_volume="145416"
bid="N/A"
bid_size="N/A"
book_value="3.30"
change="+0.00"
change_from_200_day_moving_average="-3.91"
change_from_50_day_moving_average="0.48"
change_from_52_week_high="-11.70"
change_From_52_week_low="1.50"
change_in_percent="+0.00%"
close="6.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.56"
ebitda="-19.53M"
eps_estimate_current_year="-2.81"
eps_estimate_next_quarter="-0.90"
eps_estimate_next_year="-2.84"
ex_dividend_date="N/A"
float_shares="5820000"
high="6.20"
high_52_weeks="17.70"
last_trade_date="2/10/2017"
last_trade_price="6.00"
last_trade_size="403"
last_trade_time="4:00pm"
low="5.98"
low_52_weeks="4.50"
market_capitalization="46.90M"
moving_average_200_day="9.91"
moving_average_50_day="5.52"
name="Trillium Therapeutics Inc."
notes="N/A"
one_year_target_price="16.85"
open="6.00"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-39.48%"
percent_change_from_50_day_moving_average="+8.70%"
percent_change_from_52_week_high="-66.10%"
percent_change_from_52_week_low="+33.33%"
previous_close="6.00"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.82"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="7817000"
short_ratio="2.40"
stock_exchange="NCM"
symbol="TRIL"
volume="70494"
weeks_range_52="4.50 - 17.70"
